AGP Picks
View all

Get your fresh news on health and wellness in New Hampshire

Provided by AGP

New Hampshire Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.

Press releases published on May 7, 2026

CJ Biomaterials and Yuhan-Kimberly Launch World’s First Reusable Nonwoven Paper Towel Made with Amorphous PHA
Alpha Pro Tech, Ltd. Announces First Quarter 2026 Financial Results
Marius Pharmaceuticals Announces Key Leadership Expansion and Launch of Marius AI, Positioning the Company as the First AI-Native Pharmaceutical Company
CT United FC Partners with Yale New Haven Health to Power Player Performance and Care
KALA BIO Announces Reverse Stock Split
Marlyn Expands Solid-Dose CDMO Capabilities with a Mechanistic-Integrity–Driven Manufacturing Platform
Biotech’s Next Wave May Already be in Motion
Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026
Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA
Dogwood Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
Health Monitor Network Expands Leadership Position with Acquisition of Digital HCP Marketing Company D+R Lathian
Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption
Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results
Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership
SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market
InStride Health Sustains Outstanding Clinical Results in Third Annual Outcomes Report; Announces State Expansion Across East Coast
Tria Federal Unveils Integrated Solutions Platform and New Website
AIM ImmunoTech Announces 50% Objective Response Rate (ORR) in UPMC Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential

Share us

on your social networks:

Sign up for:

New Hampshire Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.